Bill S270B-2013

Requires facilities to perform pulse oximetry screening on newborns

Requires facilities to perform pulse oximetry screening on newborns.

Details

Actions

  • Jun 12, 2013: SUBSTITUTED BY A2316B
  • Jun 11, 2013: ORDERED TO THIRD READING CAL.1216
  • Jun 11, 2013: REPORTED AND COMMITTED TO RULES
  • May 16, 2013: PRINT NUMBER 270B
  • May 16, 2013: AMEND AND RECOMMIT TO FINANCE
  • May 7, 2013: REPORTED AND COMMITTED TO FINANCE
  • Apr 25, 2013: PRINT NUMBER 270A
  • Apr 25, 2013: AMEND (T) AND RECOMMIT TO HEALTH
  • Jan 9, 2013: REFERRED TO HEALTH

Meetings

Votes

Memo

BILL NUMBER:S270B

TITLE OF BILL: An act to amend the public health law, in relation to requiring facilities to screen newborns for critical congenital heart defects through pulse oximetry screening

PURPOSE:

Requires facilities to perform pulse oximetry screening on newborns for critical congenital heart defects

JUSTIFICATION:

This bill requires each birthing facility in the state of New York be required to perform a pulse oximetry screening for critical congenital heart defects (CCHDs). For newborns, pulse oximetry screening involves taping a small sensor to a newborn's foot while the sensor beams red light through the foot to measure how much oxygen is in the blood, pulse oximetry screening is effective at detecting CHDs that may otherwise go undetected by current screening methods. Pulse oximetry screenings are non-invasive, painless, and take approximately one minute to perform. According to the United States Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children, congenital heart disease affects approximately seven to nine of every 1,000 live births in the United States and Europe; the federal Centers for Disease Control and Prevention states that CHD is the leading cause of infant death due to birth defects, and that about 4,800 babies born every year have CCHDs. Current methods used to detect CHDs include prenatal ultrasound screening, and repeated clinical examinations; however, prenatal ultrasound screenings, alone, identify less than half of all CHD cases. Many newborn lives could potentially be saved by requiring birthing facilities to incorporate pulse oximetry screening as a method for early detection of CHDs in conjunction with current CHD screening methods.

LEGISLATIVE HISTORY:

2011-12; A7941 Held in Health/S6726 Passed Senate

FISCAL IMPLICATIONS:

None to state.

EFFECTIVE DATE:

This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.


Text

STATE OF NEW YORK ________________________________________________________________________ 270--B 2013-2014 Regular Sessions IN SENATE (PREFILED) January 9, 2013 ___________
Introduced by Sens. LARKIN, ADDABBO, BOYLE, BRESLIN, GRISANTI, KENNEDY, KRUEGER, LATIMER, LAVALLE, MAZIARZ, MONTGOMERY, PERALTA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to requiring facili- ties to screen newborns for critical congenital heart defects through pulse oximetry screening THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Legislative intent. Congenital heart defects (CHDs) are structural abnormalities of the heart that are present at birth; CHDs range in severity from simple problems such as holes between chambers of the heart, to severe malformations, such as the complete absence of one or more chambers or valves; critical CHDs (CCHDs) are a subset of CHDs that cause severe and life-threatening symptoms which require inter- vention within the first days, weeks or months of life. According to the United States Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children, congenital heart disease affects approximately seven to nine of every 1,000 live births in the United States and Europe. The federal Centers for Disease Control and Prevention states that CHD is the leading cause of infant death due to birth defects and that about forty-eight hundred babies born each year have one of seven CCHDs. Current methods for detecting CHDs generally include prenatal ultra- sound screening and repeated clinical examinations; while prenatal ultrasound screenings can detect some major CHDs, these screenings,
alone, identify less than half of all CHD cases. CCHD cases are often missed during routine clinical exams performed prior to a newborn's discharge from a birthing facility. Pulse oximetry is a non-invasive test that estimates the percentage of hemoglobin in blood that is saturated with oxygen. When performed on a newborn a minimum of 24 hours after birth, pulse oximetry screening is often more effective at detecting critical, life-threatening CHDs which otherwise go undetected by current screening methods. Newborns with abnormal pulse oximetry results require immediate confirmatory testing and intervention or a referral to an appropriate health care provider for confirmatory testing and follow-up care, based on the recommendation of the treating health care provider. The legislature finds and declares that many newborn lives could potentially be saved by earlier detection and treatment of CHDs if birthing facilities in the state of New York were required to perform this simple, non-invasive newborn screening in conjunction with current CHD screening methods. S 2. Subdivision (a) of section 2500-a of the public health law, as amended by chapter 863 of the laws of 1986, is amended to read as follows: (a) It shall be the duty of the administrative officer or other person in charge of each institution caring for infants twenty-eight days or less of age and the person required in pursuance of the provisions of section forty-one hundred thirty of this chapter to register the birth of a child, to cause to have administered to every such infant or child in its or his care a test for phenylketonuria, homozygous sickle cell disease, hypothyroidism, branched-chain ketonuria, galactosemia, homo- cystinuria, CRITICAL CONGENITAL HEART DEFECTS THROUGH PULSE OXIMETRY SCREENING, and such other diseases and conditions as may from time to time be designated by the commissioner in accordance with rules or regu- lations prescribed by the commissioner. Testing, the recording of the results of such tests, tracking, follow-up reviews and educational activities shall be performed at such times and in such manner as may be prescribed by the commissioner. The commissioner shall promulgate regu- lations setting forth the manner in which information describing the purposes of the requirements of this section shall be disseminated to parents or a guardian of the infant tested. S 3. This act shall take effect on the one hundred eightieth day after it shall have become a law; provided, however, that effective immediate- ly, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized and directed to be made and completed on or before such effective date.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Discuss!

blog comments powered by Disqus